Neo Borocillina Nasale (Oxymetazoline Hydrochloride)

Oxymetazoline hydrochloride, the active ingredient in Neo Borocillina Nasale, is an alpha‑adrenergic agonist presented as a nasal spray for intranasal use. It acts as a rapid‑acting decongestant that reduces swelling of the nasal mucosa, providing relief from nasal blockage caused by the common cold, sinusitis, or allergic rhinitis in adults and children over a certain age.

GNH USA supplies Neo Borocillina Nasale as a licensed, GDP‑compliant international pharmaceutical product, meeting EU quality standards and serving hospitals, pharmacies, and clinics worldwide through its regulated distribution network.

Oxymetazoline hydrochloride is an alpha‑adrenergic agonist used to relieve nasal congestion in several upper‑respiratory conditions.

- Common cold: provides rapid reduction of nasal swelling, helping to clear the airway and improve airflow during viral upper‑respiratory infection. - Sinusitis: decreases mucosal edema in the nasal passages, supporting sinus drainage and relieving pressure associated with acute or chronic sinus inflammation. - Allergic rhinitis: mitigates congestion by constricting dilated nasal vessels triggered by allergens, thereby improving nasal patency. - Pre‑operative nasal preparation: temporarily reduces mucosal swelling to improve surgical field visibility during nasal or sinus procedures.

Oxymetazoline nasal spray may cause local or systemic adverse reactions, most of which are mild and transient.

Common Side Effects: - Nasal irritation or burning sensation: mild, transient discomfort at the site of spray application. - Sneezing: brief increase in nasal reflex causing one or more sneezes. - Dry nose or crusting: reduced moisture leading to crust formation inside the nostrils. - Headache: mild tension‑type headache that may resolve without treatment.

Serious or Rare Side Effects: - Rebound congestion (rhinitis medicamentosa): worsening nasal blockage after continuous use beyond recommended duration. - Elevated blood pressure: systemic vasoconstriction may cause a measurable rise in arterial pressure. - Palpitations or tachycardia: occasional rapid heartbeats reported in sensitive individuals. - Severe allergic reaction: rash, itching, facial swelling, or anaphylaxis requiring immediate medical attention.

When using Oxymetazoline nasal spray, certain precautions help ensure safe and effective therapy. - Age limitation: avoid use in children under six years unless directed by a healthcare professional. - Duration of use: limit treatment to no more than three consecutive days to prevent rebound congestion. - Existing cardiovascular disease: use with caution in patients with hypertension or heart disease. - Pregnancy and lactation: safety has not been established; consult a physician before use. - Drug interactions: avoid concurrent use with monoamine oxidase inhibitors or other vasoconstrictors. - Store at room temperature: keep the bottle in the original packaging, protect from moisture and direct sunlight.

Oxymetazoline may interact with certain medications, altering its effects or increasing risk of adverse events.

Major Interactions (Avoid): - Other nasal decongestants: combined use can cause excessive vasoconstriction, leading to higher systemic blood pressure and increased cardiovascular risk. - Systemic sympathomimetics (e.g., pseudoephedrine): concurrent use may amplify heart rate and blood pressure, raising the chance of nervous system stimulation.

Moderate Interactions (Monitor Closely): - Monoamine oxidase inhibitors (MAOIs): may precipitate hypertensive reactions due to additive adrenergic activity; monitor blood pressure closely. - Beta‑blockers: can blunt tachycardia that signals systemic absorption, potentially masking an early warning sign. - Antidepressants increasing norepinephrine (e.g., SNRIs, tricyclics): may add pressor effects, so blood pressure should be observed when used together.